Form 13-F position report

COCRYSTAL PHARMA INC

Reported by VIMA LLC

COCP CUSIP 19188J409 Manager CIK 0002012155

Reported 0 shares, down 231 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2024
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 3 Through Q2 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2023-12-31 387
2024-03-31 461
2024-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

3 quarters
Quarterly reported position history for COCRYSTAL PHARMA INC held by VIMA LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2024 Reduced 0 -231 (-100.0%) 0 $0 2024-08-08
Q1 2024 Added 231 +6 (2.7%) < 0.01% $461 2024-05-17
Q4 2023 New 225 +225 (0.0%) < 0.01% $387 2024-02-16

Who else reported the position

18 managers reported COCRYSTAL PHARMA INC for Q2 2024.

Managers reporting COCRYSTAL PHARMA INC in Q2 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Unchanged 275,656 0 < 0.01% $642,278 7 qtrs
RENAISSANCE TECHNOLOGIES LLC Added 129,828 +3,800 < 0.01% $302,499 7 qtrs
BlackRock Inc Unchanged 73,746 0 < 0.01% $171,828 7 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 64,832 +4,400 < 0.01% $151,089 7 qtrs
MORGAN STANLEY Added 59,300 +29 < 0.01% $138,170 7 qtrs
SUSQUEHANNA INTERNATIONAL GROUP LLP Reduced 25,052 -27,078 < 0.01% $58,371 6 qtrs
STATE STREET CORPORATION Reduced 20,543 -3,900 < 0.01% $47,865 7 qtrs
NORTHERN TRUST CORPORATION Reduced 12,171 -36 < 0.01% $28,359 7 qtrs
Bank of America Corporation Added 9,033 +58 < 0.01% $21,047 7 qtrs
Tower Research Capital LLC TRC Reduced 3,681 -3,775 < 0.01% $8,577 7 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2024
Filed
August 08, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.